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TRPV1 activity and substance P release are
required for corneal cold nociception
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As a protective mechanism, the cornea is sensitive to noxious stimuli. Here, we show that in
mice, a high proportion of corneal TRPM8+ cold-sensing ﬁbers express the heat-sensitive
TRPV1 channel. Despite its insensitivity to cold, TRPV1 enhances membrane potential
changes and electrical ﬁring of TRPM8+ neurons in response to cold stimulation. This ele-
vated neuronal excitability leads to augmented ocular cold nociception in mice. In a model of
dry eye disease, the expression of TRPV1 in TRPM8+ cold-sensing ﬁbers is increased, and
results in severe cold allodynia. Overexpression of TRPV1 in TRPM8+ sensory neurons leads
to cold allodynia in both corneal and non-corneal tissues without affecting their thermal
sensitivity. TRPV1-dependent neuronal sensitization facilitates the release of the neuropep-
tide substance P from TRPM8+ cold-sensing neurons to signal nociception in response to
cold. Our study identiﬁes a mechanism underlying corneal cold nociception and suggests a
potential target for the treatment of ocular pain.
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Cold allodynia (pain elicited by a normally innocuous coldstimulus) is a common symptom of ﬁbromyalgia, per-ipheral neuropathy, tissue injury/inﬂammation, and sen-
sitive teeth. Although most tissues lack cold hypersensitivity
under normal conditions, human psychophysical studies revealed
that: in the cornea, stimulation with low temperatures was per-
ceived as a cooling sensation with an irritative component1. The
cornea is one of the most unique tissues in the human body. It is
richly supplied by primary sensory ﬁbers from the ophthalmic
division (V1) of the trigeminal ganglia (TG). Pleasant cooling that
is innocuous to other parts of human body can induce signiﬁcant
irritation in the cornea1, which resembles pathological cold
allodynia. However, it is unclear whether corneal cold nociception
shares a common mechanism with pathological cold allodynia.
Studies have revealed that Transient Receptor Potential
Channel M8 (TRPM8) functions as the cold receptor in the
cornea and other tissues2. TRPM8 is widely expressed in corneal
afferent ﬁbers3,4, and regulates basal tearing by sensing tem-
perature drops induced by tear evaporation2. However, it remains
contentious whether TRPM8-expressing sensory ﬁbers mediate
cold nociception in the eye2,5, even though TRPM8 does mediate
cold allodynia in the skin6,7.
Cold nociception and allodynia are frequently characterized by
an irritative, burning sensation in the cornea or under pathologic
conditions in humans1. The burning sensation is usually medi-
ated by heat-sensitive channels, such as TRPV1. TRPV1 is a
cationic channel sensitive to capsaicin, protons and noxious heat
(but not cold), and mediates burning pain evoked by each of these
stimuli8,9. Its co-expression with TRPM8 is minimal in the skin
sensory ﬁbers10–12. However, 65% of cold endings respond to
capsaicin in the mouse cornea2, suggesting a high overlap
between TRPM8 and TRPV1 in the corneal sensory ﬁbers. In this
study, we conﬁrmed that a substantial proportion of corneal
TRPM8+ ﬁbers express TRPV1. Strikingly, this co-expression of
TRPV1 with TRPM8 is both necessary and sufﬁcient for cold
nociception and allodynia in the cornea, but does not alter the
corneal thermal sensitivity. As TRPV1 has been shown to display
tonic activity at body temperature13,14, the upregulation of
TRPV1 enhances excitability of TRPM8+ sensory neurons and
promotes the neuronal release of the neuropeptide substance P to
signal cold nociception. This study provides a molecular
mechanism underlying the cold nociception of the cornea and
pathological cold allodynia, and sheds light on the molecules, cells
and circuits for cold percepts.
Results
TRPM8 mediates ocular cold nociception. Utilizing Trpm8EGFPf/+
mice10, we found that TRPM8+ sensory ﬁbers branch extensively
and terminate in the superﬁcial layers of the corneal epithelium
(Fig. 1a). To determine the role of TRPM8 in cold nociception of the
cornea, we tested the response of TRPM8-deﬁcient mice to cold by
exposing their eyes to gentle air ﬂow at different temperatures. The
gentle air ﬂow (0.5 L/min) alone does not produce noxious
mechanical stimulus to the cornea, as evidenced by a lack of
behavioral responses to air ﬂow at 24 °C (room temperature) and
30 °C in mice (Fig. 1b, c). However, the air ﬂow at low and high
temperatures effectively changes the temperature of the corneal
surface (Fig. 1b; Supplementary Fig. 1) and elicits reﬂex blinking and
even eye closing in mice (Fig. 1b, c). These ocular responses were
also observed after ocular challenge with a pain-inducing compound
capsaicin (Supplementary Fig. 2), suggesting that reﬂex blinking and
eye closing are indicative behavior of ocular nociception. TRPM8-
deﬁciency abolished both reﬂex blinking and eye closing responses
to cold but not to heat (Fig. 1b, c), indicating that TRPM8 mediates
ocular cold nociception.
In addition to TRPM8 channel, TRPA1 has been shown to act
as a cold sensor15. To determine the function of TRPA1 in ocular
cold nociception, we tested the ocular responses of Trpa1−/−
mice to cold. No signiﬁcant difference was found in cold-induced
reﬂex blinking or eye closing responses between Trpa1−/− and
wild type (WT) mice (Supplementary Fig. 3), arguing against the
involvement of TRPA1 in corneal cold nociception.
Both reﬂex blinking and eye closing reduce the corneal
exposure to noxious stimuli. By monitoring changes in the
width/length ratio of the palpebral ﬁssure of the eye (Fig. 1d)16,
we found no difference between WT and Trpm8−/− mice in their
basal ratio at room temperature (Supplementary Fig. 4a).
However, the average ratio of Trpm8−/− mice in response to
cold is signiﬁcantly higher than that of WT mice and is
indistinguishable from their basal ratio (Fig. 1e, f; Supplementary
Fig. 4), indicating that TRPM8-deﬁciency impairs cold
nociception.
In addition to cold, cryosim-3 (1-diisopropylphosphorylno-
nane)17 was utilized to activate TRPM8. As a TRPM8 agonist,
cryosim-3 is more potent and speciﬁc for TRPM8 than menthol
(a classic TRPM8 agonist)17. Our previous study has shown that
application of cryosim-3 to the eyelid skin induces tearing and
alleviates dry eye symptoms in dry eye patients17. Although
cryosim-3 did not evoke nociception when applied to the eyelid
skin17, it induced reﬂex blinking and eye closing in a dose-
dependent manner when applied onto the cornea (Supplementary
Fig. 5), suggesting that activation of TRPM8 in the cornea
generates ocular nociception. Notably, eye closing was evoked
only by high doses of cryosim-3 (Supplementary Fig. 5b),
indicating that eye closing is a nocifensive behavioral response
to more intense chemical stimuli. Correlating well with this, eye
closing was evoked by more intense cold stimuli (8 and 13 °C),
but not by moderate cold (19 °C, Fig. 1c).
A high proportion of corneal TRPM8+ ﬁbers express TRPV1.
The indispensable role of TRPM8 in ocular cold nociception
raises the question of why activation of TRPM8 by innocuous
cold induces irritation/discomfort in the cornea, rather than a
pleasant cooling sensation as in the skin or other parts of the
body. Because ocular cold nociception is characterized by an
irritative, burning component1, we hypothesize that the burning
component of cold nociception is mediated by heat-sensitive
channels such as TRPV1. To test this, we examined whether
TRPV1 is co-expressed with TRPM8 in sensory neurons inner-
vating the cornea. Retrogradely labeled corneal neurons were all
located in a restricted area of the ophthalmic (V1) division of TG
(Fig. 2a). Interestingly, ~47% of labeled TRPM8+ neurons dis-
played immunoreactivity for TRPV1 (Fig. 2a, b). By contrast,
minimal co-expression of TRPM8 and TRPV1 was noted in
sensory neurons that innervate the ear skin (Fig. 2a, b). This
uniquely high overlap between TRPM8 and TRPV1 in cornea-
projecting sensory neurons was further conﬁrmed by calcium
imaging. Utilizing PirtGCaMP3/+ mice in which a calcium indi-
cator GCaMP3 was expressed in primary sensory neurons18, we
conducted ex vivo whole-ganglion calcium imaging. Consistent
with the immunostaining results, we found that approximately
half of cold-sensing neurons responded to TRPV1 agonist cap-
saicin in the cornea-projecting area within the ophthalmic divi-
sion of the TG explants (Fig. 2c, d).
TRPV1 enhances the responsiveness of TRPM8+ neurons to
cold. The ﬁnding of TRPV1 expression in a large proportion of
corneal TRPM8+ neurons prompted us to examine whether
TRPV1 regulates the response of TRPM8+ cells to cold. TRPM8
and TRPV1 were co-expressed in heterologous KNRK cells.
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Pharmacological blockade of TRPV1 using AMG9810 (a potent
and selective TRPV1 antagonist19,20) signiﬁcantly decreased the
calcium responses of the transfected cells to cold (Fig. 3a, b;
Supplementary Fig. 6), suggesting that the expression of TRPV1
enhances the responsiveness of TRPM8+ cells to cold. We further
examined the modulatory role of TRPV1 in TG sensory neurons.
AMG9810 effectively reduced the amplitude of calcium responses
to cold in ~48% of cold-sensing neurons that project to the
cornea (Fig. 3c, d), correlating well with the proportion of
TRPV1-expression or capsaicin sensitivity in TRPM8+ neurons
that innervate the cornea.
We next examined whether the expression of TRPV1 enhances
membrane depolarization and promotes action potential ﬁring. In
Trpm8EGFPf/+ mice, all capsaicin-sensitive TRPM8+ TG neurons
(identiﬁed by calcium imaging) displayed greater membrane
depolarization and ﬁred more action potentials upon cold
treatments than those insensitive to capsaicin (Fig. 3e–g),
suggesting that the expression of TRPV1 promotes neuronal
excitability to cold. Indeed, AMG9810 treatment signiﬁcantly
reduced the membrane depolarization and hence action potential
ﬁring in capsaicin-sensitive TRPM8+ neurons (Fig. 3k–m). As a
control, vehicle treatment did not alter the membrane depolar-
ization or action potential ﬁring (Fig. 3h–j). These studies support
an indispensable role of TRPV1 in potentiating the response of
TRPM8+ neurons to cold.
TRPV1 is required for TRPM8-mediated cornea cold noci-
ception. The discovery that TRPV1 promotes excitability of
TRPM8+ neurons raises the question of whether TRPV1 facil-
itates cold nociception of the cornea. Although TRPV1 is not
activated by cold21, we found that Trpv1−/− mice completely
lacked the eye closing response to cold. In contrast, their reﬂex
blinking response was not signiﬁcantly reduced (Fig. 4a-c), sug-
gesting that TRPV1 is required to produce intense nocifensive
behavioral response. Correlating well with this result, pharma-
cological blockade of TRPV1 in the cornea using AMG9810
abolished the eye closing response to cold (13 °C) and increased
the width/length ratio to the extent similar to that of TRPV1-
deﬁcient mice (Fig. 4d). These studies demonstrate that TRPV1
facilitates TRPM8-mediated cold nociception in the cornea.
Of note, the nociceptive deﬁcit of Trpv1−/− mice to cold is not
due to a poor survival of corneal TRPM8+ sensory neurons
(Fig. 4e, f) or their defective projections to the cornea or brain-
stem (Fig. 4g, h).
TRPV1 is required for dry eye-induced cold allodynia. Under
dry eye conditions, corneal cold nociception is further enhanced
and leads to cold allodynia22. To investigate whether TRPV1 is
involved in dry eye-induced cold allodynia, we generated a dry
eye model in mice by surgically removing their exorbital lacrimal
glands (intraorbital lacrimal glands remain intact)23. In this
model, tear secretion was signiﬁcantly reduced, and the epithelial
erosions of the cornea were remarkably increased as revealed
under a cobalt blue light after ﬂuorescein staining (Fig. 5a–c). We
found that Trpv1−/− mice displayed normal basal tear secretion
before the dry eye surgery. After surgery, Trpv1−/− mice showed
similar extents of reduced tear secretion and intensiﬁed corneal
epithelial erosions as WT controls (Fig. 5b, c), indicating that
TRPV1 is not involved in the pathogenesis of dry eye in this
model.
After establishment of chronic dry eye (4 weeks after surgery),
we found that the percentage of TRPM8+ neurons is not altered
(Supplementary Fig. 7). However, TRPV1 is signiﬁcantly
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Fig. 1 TRPM8 mediates cold-induced ocular nociception. a Representative image showing that TRPM8-expressing sensory ﬁbers (green) densely
innervate the cornea as revealed by TRPM8-EGFPf in the whole-mount cornea from Trpm8EGFPf/+ mice. b, c The reﬂex blinking and eye closing responses
to air ﬂow (0.5 L/min) at different temperature in WT (n= 7–10) and Trpm8−/− (n= 10–13) mice. d Representative video frames showing the opening and
closing of the mouse eye (outlined by white dash lines). Red dash lines indicate the width and length of the palpebral ﬁssure. e The representative width/
length ratio changes of WT and Trpm8−/− mice in response to cold air (13 °C). Black arrows indicate reﬂex blinking responses. f The average width/length
ratio of WT mice (n= 7) is signiﬁcantly lower than that of Trpm8−/− mice (n= 6) in response to cold air (13 °C). Data are expressed as mean ± s.e.m.
Statistical analysis by two tailed Student’s t-test. **P < 0.01; ***P < 0.001. All images shown are representative of three independent experiments using
tissues from at least three different mice. Scale bar: 100 µm. Source data are provided as a Source Data ﬁle.
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compared with sham-operated mice (Fig. 5d). Correlating well
with this observation, more cold-sensitive neurons responded to
capsaicin in the cornea-projection area of TG from dry eye mice
(Fig. 5e), suggesting an enhanced nociceptive function of corneal
TRPM8+ sensory ﬁbers under dry eye conditions. Indeed, using
normally innocuous doses of cryosim-3, activation of corneal
TRPM8+ sensory ﬁbers evoked nocifensive behavior in dry eye
mice but not in sham-operated mice (Fig. 5f). Furthermore, dry
eye mice displayed cold allodynia and showed eye closing
response to air ﬂow at 19 °C, which was not observed in sham-
operated mice (Fig. 5g). These results conﬁrmed an increased
nociceptive function of corneal TRPM8+ sensory ﬁbers under dry
eye conditions, which was not found in previous study mainly
due to discrepancy in methodologies (Supplementary Fig. 8)24.
Trpv1−/− mice with dry eye displayed signiﬁcantly reduced eye
closing responses to cryosim-3 and innocuous cold stimulus
(19 °C), compared with WT controls (Fig. 5f, g). Furthermore,
pharmacological blockade of TRPV1 using AMG9810 effectively
alleviated dry eye-associated cold allodynia in WT mice (Fig. 5h).
Together, these results indicate that TRPV1 is indispensable for
dry eye-induced cold allodynia, and pharmacological suppression
of TRPV1 is a promising therapeutic strategy for dry eye-
associated cold allodynia.
TRPV1 overexpression in TRPM8+ neurons causes cold allo-
dynia. Although our gene deletion and pharmacological blockade
assays have shown that TRPV1 is necessary for dry eye-associated
cold allodynia, it is unclear whether the upregulation of TRPV1 in
TRPM8+ neurons alone (without dry eye) is sufﬁcient for gen-
erating cold allodynia. To address this question, we generated
Trpm8CreER/+; ROSA26Trpv1/+ mice in which TRPV1 is selec-
tively overexpressed in TRPM8+ neurons (Fig. 6a). This line
mimics the upregulation of TRPV1 in TRPM8+ neurons under
pathological conditions without affecting the TRPV1 expression
in TRPM8-negative neuronal populations. Moreover, this line
circumvents dry eye-associated pathological changes and
inﬂammation, which may introduce confounding factors in
studying the involvement of TRPV1.
We ﬁrst examined the expression of the Trpv1 transgene in
TRPM8+ neurons by conducting calcium imaging of primary
sensory neurons. Of TRPM8+ TG neurons (identiﬁed by their
responsiveness to cryosim-3) from control ROSA26Trpv1/+ mice,
34.10% ± 2.33% responded to capsaicin (Fig. 6b, c). In contrast,
81.14% ± 0.91% of TRPM8+ neurons from Trpm8CreER/+;
ROSA26Trpv1/+ mice were sensitive to capsaicin, suggesting that




































































Fig. 2 TRPV1 is co-expressed with TRPM8 in corneal sensory neurons. a Representative images showing a higher overlap between TRPM8-EGFPf and
TRPV1-immunoreactivity (IR) in cornea-projecting neurons (retrogradely labeled by ﬂuorogold from the cornea) than in skin-projecting neurons
(retrogradely labeled by ﬂuorogold from the ear skin). White arrows indicate ﬂuorogold+/TRPM8+/TRPV1+ neurons, whereas hollow arrows indicate
ﬂuorogold+/TRPM8+/TRPV1− neurons. b Quantiﬁcation of the co-expression of TRPV1 with TRPM8 in sensory neurons innervating the cornea and ear
skin, respectively (n= 3 mice/group). c Representative neuronal calcium responses to cold, capsaicin (10 µM), and KCl (100mM) within the cornea-
projection area in the ophthalmic division of the trigeminal ganglion explants from PirtGCaMP3/+ mice in which a calcium indicator GCaMP3 was expressed
in primary sensory neurons. d Quantiﬁcation of capsaicin responses in 56 cold-sensitive neurons located within the cornea-projection area of four
trigeminal ganglia from three PirtGCaMP3/+ mice. Cap: capsaicin. Data are expressed as mean ± s.e.m. Statistical analysis by two tailed Student’s t-test.
**P < 0.01. All images shown are representative of three independent experiments using tissues from at least three different mice. Scale bars in a 100 μm.
Source data are provided as a Source Data ﬁle.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13536-0


























































































































































































1st cold 2nd cold
1st cold 2nd cold 1st cold 2nd cold







































Fig. 3 TRPV1 enhances the responsiveness of TRPM8-expressing cells to cold. a, b TRPV1 antagonist AMG9810 (AMG, 300 nM, 3min pre-treatment
before cold stimulation) attenuated calcium responses to cold in transfected KNRK cells that co-express TRPM8 and TRPV1. As a control, the vehicle
treatment did not change their response to cold or capsaicin (Cap, 1 µM). Cold stimulation was generated by bath temperature drop from 32 °C to 15 °C.
Each dot in b represents a KNRK cell that co-expresses TRPM8 and TRPV1. c Representative calcium transients of sensory neurons to cold stimuli after
10min pre-treatment of vehicle (0.0006% DMSO in calcium imaging buffer) or AMG9810 (300 nM). Imaged neurons were located within the cornea-
projection area in the ophthalmic division of the whole trigeminal ganglion explants (n= 7) from PirtGCaMP3/+ transgenic mice, in which a calcium indicator
GCaMP3 was expressed in primary sensory neurons. The expression of TRPV1 in tested neurons was determined by their responses to capsaicin (10 µM).
d Quantiﬁcation of calcium responses of trigeminal neurons to cold. Each dot represents one cold-sensing neuron. e–g Cold treatments elicited greater
membrane potential changes (ΔMP) and more action potentials (APs) in a subset of TRPM8EGFPf/+ sensory neurons that are sensitive to capsaicin (1 µM,
identiﬁed by calcium imaging) than those insensitive to capsaicin. h–j Repeated cold treatments did not desensitize TRPM8EGFPf/+; TRPV1+ sensory
neurons in the vehicle control group, as shown by stable membrane potential changes and neuronal ﬁring. k–m Application of TRPV1 antagonist AMG9810
(300 nM, 10min pre-treatment before cold stimulation) effectively suppressed depolarization and neuronal ﬁring in capsaicin-sensitive TRPM8EGFPf/+
neurons upon subsequent cold treatment. Data are expressed as mean ± s.e.m. Statistical analysis by two tailed Student’s t-test. **P < 0.01; ***P < 0.001.
Source data are provided as a Source Data ﬁle.
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To conﬁrm the overexpression of TRPV1 in TRPM8+ neurons
from Trpm8CreER/+; ROSA26Trpv1/+ mice, we generated
Trpm8CreER/+; ROSA26Trpv1/tdTomato mice in which TRPM8+
neurons express both Trpv1 and tdTomato transgenes. We found
that signiﬁcantly more tdTomato-labeled TRPM8+ neurons
express TRPV1 in Trpm8CreER/+; ROSA26Trpv1/tdTomato mice
than in control Trpm8CreER/+; ROSA26tdTomato/+mice which lack
the Trpv1 transgene (Fig. 6d, e), correlating well with our calcium
imaging results.
We next examined the behavioral consequence of TRPV1
overexpression in TRPM8+ neurons. Trpm8CreER/+; ROSA26Trpv1/+
mice displayed signiﬁcantly enhanced responses to both cryosim-
3 and innocuous cold (19 °C), compared with littermate controls
(Fig. 6f, g). This ﬁnding supports that TRPV1 upregulation in
TRPM8+ neurons alone is sufﬁcient for generating ocular cold
allodynia. In contrast, the ocular response to heat was not altered
in this transgenic mouse line (Fig. 6h), arguing against the effects
of TRPV1 upregulation in TRPM8+ neurons on the thermal
sensitivity of the cornea.
To determine whether the upregulation of TRPV1 is
required for cold allodynia in tissues other than the cornea,
we further examined whether the overexpression of TRPV1
results in similar cold allodynia in the skin. Trpm8CreER/+;
ROSA26Trpv1/+ mice display cold allodynia in response to
acetone applied to the hind paw skin (Fig. 6i), but an unaltered
response to heat stimulation in the Hargreaves test (Fig. 6j).
This ﬁnding indicates that the overexpression of TRPV1 in
TRPM8+ neurons evokes cold allodynia, but does not change
the thermal sensitivity of the skin. It provides a mechanism for
skin cold allodynia under pathological conditions. Correlating
well with the gain-of-function assay, TRPV1 deﬁciency results
in less severe cold allodynia in the inﬂammatory pain model
induced by complete Freund's adjuvant (Supplementary
Fig. 9), substantiating an indispensable role of TRPV1 in cold
allodynia. In summary, our results indicate that targeted
overexpression of TRPV1 in TRPM8+ neurons is sufﬁcient for
generating cold allodynia in both the cornea and skin.
TRPV1 facilitates substance P release and cold nociception. To
understand the neural mechanism by which the co-expression of















































































































Fig. 4 TRPV1 is required for ocular cold nociception. a, b Although the reﬂex blinking response to cold was not altered in Trpv1−/− mice (n= 8), their eye
closing responses were eliminated, compared with WT controls (n= 7). c The ocular width/length ratio of Trpv1−/− mice (n= 8) in response to cold
(13 °C) was signiﬁcantly greater than that of WT mice (n= 7), but lower than that of Trpm8−/− mice (n= 6). d The ocular width/length ratio in response to
cold (13 °C) was increased in WT mice pre-treated with TRPV1 antagonist AMG9810 (0.2 nmol in 2 μL, 10min before cold challenge; n= 5) compared with
controls pre-treated with the vehicle (0.1% Tween-80 in saline; n= 5). e, f Representative images and group analysis show that TRPV1-deﬁciency did not
impair the survival of corneal TRPM8-EGFPf neurons (retrogradely labeled by ﬂuorogold from the cornea) in Trpv1−/−; Trpm8EGFPf/+mice (n= 3), compared
with control Trpv1+/+; Trpm8EGFPf/+ mice (n= 3). g Representative image showing that TRPM8-EGFPf sensory ﬁbers (green) densely innervate the whole-
mount cornea from Trpv1-/-; Trpm8EGFPf/+ mice. h Representative image showing the central projection of TRPM8-EGFPf ﬁbers within the cornea-projection
region in the spinal trigeminal nucleus of Trpv1−/−; Trpm8EGFPf/+ mice. Data are expressed as mean ± s.e.m. Statistical analysis by one-way ANOVA and two
tailed Student’s t-test. n.s. not signiﬁcant; *P < 0.05; **P < 0.01; ***P < 0.001. All images shown are representative of three independent experiments using
tissues from at least three different mice. Scale bars in e, g, h 50, 100, and 250 μm, respectively. Source data are provided as a Source Data ﬁle.
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Fig. 5 TRPV1 is required for dry eye-induced cold allodynia. a Representative images showing dry eye-associated corneal abrasion as revealed under a
cobalt blue light after ﬂuorescein staining. b, c Trpv1−/− mice (n= 7) display normal basal tear secretion (D0) and similar extents of reduced tear secretion
and intensiﬁed corneal epithelial erosions as control WT mice (n= 12) after surgical removal of exorbital lacrimal glands. Sham-operated WT (n= 11) or
Trpv1−/− mice (n= 6) do not show reduced tear secretion or corneal abrasion. d Representative images and group analysis show that the expression of
TRPV1 was signiﬁcantly increased among corneal TRPM8-EGFPf neurons (retrogradely labeled by ﬂuorogold) in dry eye Trpm8EGFPf/+ mice (n= 4),
compared with sham-operated mice (n= 4). White arrows indicate ﬂuorogold+/TRPM8+/TRPV1+ neurons. e The proportion of cold-sensitive neurons
that display capsaicin sensitivity was signiﬁcantly greater in the dry eye group (n= 5), compared with the sham group (n= 3). f TRPM8-agonist cryosim-3
(0.025 nmol in 1 μL) elicited ocular nociception in dry eye WT mice (n= 6), but not in sham-operated WT mice (n= 5). Trpv1−/− mice (n= 5) displayed
signiﬁcantly attenuated ocular nociception induced by cryosim-3 under dry eye conditions. g Innocuous cold (19 °C) elicited ocular nociception-associated
eye closing in dry eye WT mice (n= 9), but not in sham-operated WT mice (n= 5). The eye closing response was signiﬁcantly reduced in dry eye
Trpv1−/− mice (n= 7). h The effects of the TRPV1 antagonist AMG9810 (0.2 nmol in 2 μL) on ocular cold allodynia of dry eye WT mice (n= 7) at different
post-treatment time points, compared with vehicle-treated control mice (n= 6). All the experiments in d–h were done four weeks after dry eye surgery.
Data are expressed as mean ± s.e.m. Statistical analysis by one-way ANOVA and two tailed Student’s t-test. *P < 0.05; **P < 0.01; ***P < 0.001. All images
shown are representative of three independent experiments using tissues from at least three different mice. Scale bar: 100 μm. Source data are provided as
a Source Data ﬁle.
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nociception, we investigated the potential neurotransmitters/
neuromodulators in signaling ocular cold nociception. We rea-
nalyzed one previously published dataset of TG neuronal tran-
scriptional proﬁles at the single cell level (GEO database,
accession number GSE101984)25. In addition to vesicular gluta-
mate transporter 2, substance P (encoded by Tac1 gene) is
unexpectedly highly expressed by a majority of TRPM8+ neurons
in TG (Fig. 7a and Supplementary Fig. 10). To conﬁrm the
expression of substance P in corneal sensory neurons, we
manually picked TG neurons that were retrogradely labeled by
WGA-AF555 from the cornea. Single cell RT-PCR indicated that
all TRPM8+; TRPV1+ neurons express substance P (Tac1), while
fewer TRPM8+; TRPV1- neurons express Tac1 (Fig. 7b).
To determine whether substance P is a neurotransmitter for
signaling ocular cold nociception, we examined the release of
substance P after cold stimulation of dissociated sensory neurons
(bath temperature drop from 32 °C to 15 °C). Indeed, cold
induces a signiﬁcant release of substance P (Fig. 7c). This release
was suppressed by pre-desensitization of TRPM8+ neurons using
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TRPM8+ neurons in response to cold. Studies have shown that
higher frequencies of primary afferent stimulation are required to
evoke the release of substance P, compared with that of
glutamate26,27. As pharmacological blockade of TRPV1 using
AMG9810 signiﬁcantly reduces the depolarization and ﬁring of
TRPM8+ neurons, we examined whether similar treatments of
AMG9810 reduces the release of substance P. Indeed,
AMG9810 signiﬁcantly reduced cold-induced substance P release
from sensory neurons (Fig. 7c), suggesting that TRPV1
potentiates the release of substance P upon cold stimulation. To
determine whether TRPV1 promotes cold nociception in a
substance P-dependent manner, we examined whether substance
P is required for signaling cold nociception. We found that Tac1
deﬁciency signiﬁcantly reduces eye closing as well as reﬂex
blinking responses to cold (Fig. 7d), supporting that substance P
is required for signaling ocular cold nociception.
We further examined whether substance P interacts with its
postsynaptic receptor NK1 for synaptic transmission of cold
nociceptive signal. Intracisternal injection of the NK-1 antagonist
L733,060 hydrochloride into WT mice signiﬁcantly reduced their
reﬂex blinking and eye closing responses to cold and cryosim-3
(Fig. 7e, f), supporting that NK-1 is required for synaptic
transmission of corneal TRPM8+ cold-sensitive neurons. Collec-
tively, our results indicate that the expression of TRPV1 in
TRPM8+ neurons facilitates cold-induced release of substance P,
which interacts with postsynaptic NK1 receptors for signaling
cold nociception (Fig. 7g).
Discussion
Our results reveal a previously unrecognized function of TRPV1
in promoting ocular cold nociception. The expression of TRPV1
deﬁnes two major subsets of TRPM8+ sensory ﬁbers in the mouse
cornea (TRPV1+ vs. TRPV1-). We found that the TRPV1+ subset
displays greater membrane depolarization and ﬁres more action
potentials than the TRPV1- subset. This co-expression of TRPV1
and TRPM8 is required for cold nociception and allodynia by
enhancing responsiveness of TRPM8+ neurons to cold and
facilitating the release of neuropeptide substance P. Substance P is
indispensable for the communication of TRPM8+ neurons with
postsynaptic neurons for cold nociceptive signaling.
Under pathological dry eye conditions, the expression of
TRPV1 is further upregulated in TRPM8+ neurons. This corre-
lates well with a previous ﬁnding that TRPV1 protein levels were
increased in anterior eye segment and trigeminal ganglion sam-
ples from rats with dry eyes, whereas TRPM8 levels were not
affected24. The upregulation of TRPV1 in TRPM8+ neurons leads
to severe cold allodynia, which can be effectively attenuated by
genetic deletion or pharmacological blockade of TRPV1. Impor-
tantly, TRPV1 upregulation is not only necessary but also sufﬁ-
cient for generating cold allodynia. In the absence of pathological
changes, targeted overexpression of TRPV1 in TRPM8+ sensory
neurons using molecular genetics is sufﬁcient for generating cold
allodynia in both the corneal and skin.
The up-regulation of TRPV1 may represent a general
mechanism that enhances excitability of TRPM8+ cold-sensing
neurons and other sensory neurons. Studies have shown that
TRPV1 displays tonic activity at body temperature13,14. The up-
regulation of TRPV1 may lead to spontaneous activity in corneal
TRPM8+ neurons. Indeed, studies have shown that the cold-
sensitive ﬁbers in the cornea display the ongoing impulse activity
at 34 °C2. The expression of TRPV1 may be essential to this
ongoing activity in TRPM8+ sensory ﬁbers and enable TRPM8+
neurons to depolarize and ﬁre action potentials more readily, the
latter of which has been supported by our electrophysiological
recording results in Fig. 3.
However, this enhanced neuronal excitability mediated by
TRPV1 does not alter the thermal sensitivity of mice, based on
ours and others' studies26,27. Previous studies have shown that
ablation of TRPM8+ neurons leads to cold insensitivity, but does
not alter the thermal sensitivity28,29, suggesting that TRPM8+
neurons are speciﬁc for cold perception and are not required for
thermal sensitivity. Hence TRPV1 expressed in TRPM8+ neurons
is not necessary for thermal sensitivity. Our results further show
that targeted overexpression of TRPV1 in TRPM8+ neurons does
not cause altered thermal responses in both the cornea and skin
(Fig. 6), substantiating the dispensable role of TRPV1 in
TRPM8+ neurons in regulating thermal sensitivity.
The unexpected role of TRPV1 in corneal cold-sensing ﬁbers
suggests its potential as a therapeutic target for ocular cold allo-
dynia. The high co-expression of TRPV1 and TRPM8 in primary
afferent ﬁbers is unique to the cornea, but not other tissues
examined, revealing a mechanism underlying the tissue difference
in nociceptive sensitivity to cold. Of note, although TRPM8 is
required for ocular cold nociception, it is not a good drug target for
ocular pain management, as it regulates basal tearing and main-
tains the ocular surface wetness2. Antagonizing TRPM8 for alle-
viating dry eye-associated cold allodynia can reduce basal tearing
and aggravate dry eye symptoms. In contrast, TRPV1, as a noci-
ceptive channel, is a more promising drug target than TRPM8 for
treating cold allodynia. Our previous studies have shown that
antagonizing TRPV1 could effectively block histamine-dependent
itch in allergic conjunctivitis30, suggesting a potentially wide use of
TRPV1 antagonists in alleviating ocular discomforts associated
with different ocular conditions. Furthermore, the activation of
TRPM8+/TRPV1+ neurons by cold causes the release of substance
Fig. 6 TRPV1 overexpression in TRPM8+ neurons results in cold allodynia. a Schematic diagram for the generation of Trpm8CreER/+; ROSA26Trpv1/+ mice.
b Representative calcium transients of TRPM8+ neurons in response to the TRPM8 agonist cryosim-3 (10 µM) and TRPV1 agonist capsaicin (Cap, 1 µM) in
Trpm8CreER/+; ROSA26Trpv1/+ mice and control ROSA26Trpv1/+ mice. c Quantiﬁcation indicates that a signiﬁcantly increased fraction of TRPM8+ neurons
respond to capsaicin in Trpm8CreER/+; ROSA26Trpv1/+ mice (n= 5), compared with control ROSA26Trpv1/+ mice (n= 3). d Representative images showing
TRPV1-immunoreactivity (TRPV1-IR, green) in tdTomato-labeled TRPM8+ neurons (Tdt, red) from Trpm8CreER/+; ROSA26Trpv1/tdTomato and control
Trpm8CreER/+; ROSA26tdTomato/+ mice. Arrows indicate TRPV1+/TRPM8+ neurons. e Quantiﬁcation showing upregulated TRPV1-IR in TRPM8+ neurons
from Trpm8CreER/+; ROSA26Trpv1/tdTomato mice (n= 3), compared with control Trpm8CreER/+; ROSA26tdTomato/+ mice (n= 3). f TRPM8-agonist cryosim-3
(0.025 nmol in 1 μL) evoked signiﬁcantly more reﬂex blinking in Trpm8CreER/+; ROSA26Trpv1/+ mice (n= 7) than in control ROSA26Trpv1/+ mice (n= 6). The
vehicle (0.9% NaCl) did not induce signiﬁcant reﬂex blinking in either Trpm8CreER/+; ROSA26Trpv1/+ (n= 7) or ROSA26Trpv1/+mice (n= 6). g Innocuous cold
(19 °C) evoked signiﬁcantly more reﬂex blinking in Trpm8CreER/+; ROSA26Trpv1/+ mice (n= 7) than in control ROSA26Trpv1/+ mice (n= 6). h Noxious heat
(45 °C) elicited similar ocular nociception-associated reﬂex blinking responses in both Trpm8CreER/+; ROSA26Trpv1/+ (n= 7) and control ROSA26Trpv1/+ mice
(n= 6). i Evaporative cooling evoked by acetone applied onto the paw skin elicited more signiﬁcant nociception-associated ﬂicking and licking responses in
Trpm8CreER/+; ROSA26Trpv1/+ mice (n= 6) than in control ROSA26Trpv1/+ mice (n= 6). j Trpm8CreER/+; ROSA26Trpv1/+ (n= 7) and control ROSA26Trpv1/+
mice (n= 6) display similar sensitivity to heat in the Hargreaves test. Data are expressed as mean ± s.e.m. Statistical analysis by two tailed Student’s t-test.
n.s. not signiﬁcant; *P < 0.05; ***P < 0.001. All images shown are representative of three independent experiments using tissues from at least three different
mice. Scale bar: 100 μm. Source data are provided as a Source Data ﬁle.
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P, which has been shown to mediate neurogenic inﬂammation31,32.
Pharmacological blockade of TRPV1 decreases substance P release
(Fig. 7c), and hence would attenuate associated inﬂammation and
disease progression. Finally, the upregulation of TRPV1 in
TRPM8+ neurons is sufﬁcient to generate cold allodynia in both
corneal and non-corneal tissues, which offers a general mechanism
underlying cold allodynia associated with different conditions in
different tissues. We have shown that TRPV1 is required for cold
allodynia under inﬂammatory pain conditions in the skin (Sup-
plementary Fig. 9). It would be interesting to further study whether
TRPV1 is involved in cold allodynia associated with sensitive teeth
and ﬁbromyalgia affecting bones and muscles. In summary, our
study sheds light on unexpected functions of TRPV1 in cold
nociception and provides a common mechanism behind the cor-
neal cold nociception and pathological cold allodynia, which opens
an avenue for pain management.
Methods
Animals. C57BL/6J wild-type (WT, Stock#: 000664), Trpm8−/− (Stock#: 008198),
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Fig. 7 Substance P release is required for corneal cold nociception. a The expression of neuropeptides in mouse TRPM8+ trigeminal ganglionic (TG)
neurons based on single-cell RNA-seq data. Each dot represents a single TRPM8+ neuron. Full dataset and methods are available in Nguyen et al.25.
b Single-cell RT-PCR using intron-spanning primers was performed on individual TRPM8-EGFPf sensory neurons that project to the cornea. All TRPM8+/
TRPV1+ neurons express substance P (Tac1), while fewer TRPM8+/ TRPV1- neurons express Tac1. Negative control (−): No reverse transcription reaction
on RNA sample from whole TG. Positive control (TG): cDNA from whole TG. c Cold treatments (bath temperature drops from 32 to15 °C) promote the
release of substance P from dissociated trigeminal neurons, as revealed by ELISA assays. TRPV1 antagonist AMG9810 (AMG, 300 nM, 3 min pre-
treatment before cold stimulations) suppressed the release of substance P, compared with the vehicle control (0.0006% DMSO). Cold-associated release
of substance P was also suppressed by pre-desensitization of TRPM8+ neurons using TRPM8 agonist cryosim-3 (10 µM). d Both the reﬂex blinking and eye
closing responses to air ﬂow at 13 °C were signiﬁcantly reduced in Tac1−/− mice, compared with WT controls (n= 5 mice/group). e–f NK1 antagonist
alleviates cold nociception. The reﬂex blinking and eye closing responses to cold (air ﬂow at 13 °C) and cryosim-3 (0.1 nmol in 1 μL) were signiﬁcantly
reduced 30min after intracisternal injection of NK1 antagonist L733,060 hydrochloride (10 µg in 5 µL, n= 5 mice), compared with the vehicle-treated
group (0.9% NaCl, n= 5 mice). g Model for neural pathways encoding corneal cold nociception and allodynia. SP: substance P. Data are expressed as
mean ± s.e.m. Statistical analysis by two tailed Student’s t-test. * P < 0.05, **P < 0.01, ***P < 0.001. Source data are provided as a Source Data ﬁle.
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004103) and ROSA26tdTomato/+ (Stock#: 007905) mice were ordered from Jackson
Laboratory. PirtGCaMP3/+ mice18 were gifted by Dr. Xinzhong Dong at Johns
Hopkins University. Trpm8EGFPf/+ mice10 were gifted by Dr. Gina Story when she
worked at Washington University Pain Center. Trpm8creER/+ mice were from Dr.
Hongzhen Hu at Washington University Center for the Study of Itch and Sensory
Disorders. All transgenic animals used for behavioral experiments were back-
crossed to the C57BL/6J background, and all mice were between two and three
months old at the time of experiment. Researchers were blinded to mouse genotype
throughout experiment and analysis. All experimental procedures were approved
by the Institutional Animal Care and Use Committee at Washington University in
St. Louis, School of Medicine, and complied with all relevant ethical regulations for
animal testing and research.
Cold and heat stimulations of the cornea. Cold and heat stimulations were
applied using temperature-controlled air ﬂow. Brieﬂy, gentle air ﬂow (0.5 L/min)
passed through a PVC tube immersed into water bath, where the temperature was
adjusted until the outﬂow air is maintained stably at the desired experimental
temperatures. During testing, mice were restrained manually and their eyes were
placed 5 mm away from the air ﬂow. Blinking and eye closing responses were
videoed for 10 s. Blinking is rapid, forceful eye closing followed by immediate eye
opening. In contrast, eye closing reﬂects signiﬁcant ocular width/length ratio
changes over time and is not followed by immediate eye opening. In our study,
mice display obvious eye closing when their ocular width/length ratio drops by 50%
or more from their basal ratio. The ocular width/length ratio was calculated based
on the measurement of the width and length of the palpebral ﬁssure16.
Chemical application to the cornea. After acclimation, test animals were manually
restrained and test compounds (e.g. capsaicin, cryosim-3, menthol, isotonic and
hypertonic saline) were carefully applied onto the cornea using a pipette. Blinking
and eye closing responses were scored for 10 s immediately after chemical application.
Retrograde labeling. Adult mice were anesthetized with ketamine (100 mg/kg)
and xylazine (10 mg/kg) cocktail and placed under a stereoscopic dissection
microscope. Approximately 0.5 μL of 4% ﬂuorogold (Cat# 80014, Biotium) or
5 mg/mL WGA-Alexa Fluor® 555 (W32464, Life Tech) in PBS was injected into the
cornea with a pulled glass micropipette. Mice were euthanized for immunohis-
tochemistry staining, single cell PCR or whole trigeminal ganglia calcium imaging
three days after dye injection.
Immunoﬂuorescence staining. Mice were perfused with ice cold PBS (pH 7.4)
followed by 4% paraformaldehyde (PFA) in PBS after CO2 euthanasia. Trigeminal
ganglia (TG) and brainstems were dissected and post-ﬁxed in 4% PFA at 4 °C for
30 min and 4 h, respectively. Tissues were cryoprotected in 30% (w/v) sucrose
overnight at 4 °C and frozen in OCT for sectioning. TG was sectioned at 12 μm
onto slides and brainstem was sectioned at 30 μm for ﬂoating staining. Immu-
noﬂuorescence staining was done as in a previous study33. Brieﬂy, sectioned tissues
were blocked with 10% goat serum in PBST (PBS containing 0.1% Triton X-100)
for 1 h and incubated with primary antibodies at 4 °C overnight. After rinsing,
sections were incubated with secondary antibody for 2 h at room temperature.
Images were taken and analyzed using Nikon ﬂuorescence microscope with a
CoolSnap HQ2 CCD camera (Photometrics, Tucson, AZ).
Primary antibodies used: rabbit anti-TRPV1 (VR1-C; RA14113; Neuromics;
1:1000), chicken anti-GFP (GFP-1020; Aves Lab; 1:1000).
Secondary antibodies used: goat anti-rabbit IgG (Alexa Fluor-555; A21429, Life
technologies; 1:500), donkey anti-chicken IgG (114050, FITC conjugated; Jackson
ImmunoResearch; 1:500).
Calcium imaging. KNRK cells were co-transfected with TRPM8 and TRPV1
plasmids34,35. KNRK cells were derived from normal rat kidney transformed by
Kirsten sarcoma virus (ATCC® CRL-1569™), and have been widely used for het-
erologous expression of G-protein couple receptors and channels36–41.
Transfected KNRK cells or dissociated TG neurons from Trpm8CreER/+;
ROSA26Trpv1/+ mice were loaded with Fura-2 (Molecular Probes, F1221) in
calcium imaging buffer (CIB, containing (in mM): NaCl 130, MgCl2 0.6, KCl 3,
NaHCO3 1.2, CaCl2 2.5, HEPES 10, and glucose 10, pH 7.40) for 40 min and
recovered for 10 min before assay. Whole-mount TG from PirtGCaMP3/+ mice were
dissected and recovered for 60–90 min at RT in freshly prepared synthetic
interstitial buffer (SIF, containing (in mM): NaCl 107.8, MgSO4 0.69, KCl 3.5,
CaCl2 1.53, NaH2PO4 1.67, NaHCO3 26.2, C6H11NaO7 9.64, glucose 5.55, sucrose
7.6, bubbled with 5% CO2 balanced O2 to yield pH 7.40 before use). The
temperature of bath (CIB for cultured cells and SIF for whole TG) was controlled
by a dual in-line heater/cooler regulator (Warner Instruments, SC-20). The cold
stimulation was generated by bath temperature drop from 32 °C to 15 °C.
Compounds including capsaicin (Sigma, M2028), AMG9810 (Tocris, 2316), and
KCl were bath applied. AMG9810 was dissolved in DMSO as stock solution and
diluted to 300 nM with CIB or SIF immediately before use. The pretreatment of
AMG9810 or vehicle (diluted DMSO in CIB) was 3 min for transfected KNRK
cells, and 10 min for sensory neurons before cold stimulation. Cellular response
was acquired using an inverted Nikon ﬂuorescence microscope with a CoolSnap
HQ2 CCD camera (Photometrics) and quantiﬁed ofﬂine with the Nikon-NIS
program. A minimal 15% increase of ΔF/F0 in 340/380 ratio or GCaMP3
ﬂuorescence intensity were used as threshold response.
Electrophysiology. Dissociated TRPM8+ TG neurons from Trpm8EGFPf/+ mice
were ﬁrst screened for capsaicin sensitivity using calcium imaging. Whole-cell
current-clamp recordings were performed using a MultiClamp 700B ampliﬁer
and pCLAMP 10.5 software (Axon Instruments). Internal solution contained
(in mM): K+-gluconate 120, KCl 30, MgCl2 2, HEPES 10, MgATP 2, CaCl2 1,
EGTA 11, with pH adjusted to 7.2 using Tris-base. Neurons were continuously
perfused (2–3 mL/min) with external solution containing (in mM): NaCl 145,
KCl 3, CaCl2 2, MgCl2 2, glucose 10 and HEPES 10, pH 7.4. Solution temperature
was maintained at 33 °C using a dual in-line heater/cooler regulator (Model SC-20,
Warner Instruments, Hamden, CT 06514).
Resting membrane potential (RMP) was recorded after stabilization (within
4 min) and unhealthy neurons (with RMP >−45 mV) were excluded from the
study. Cold stimulation was introduced by lowering the bath temperature to 10 °C.
Neurons were allowed to recover for ~10 min at 33 °C, before bath perfusion of
AMG9810 or vehicle containing external solution.
Mouse dry eye model. Adult mice were anesthetized using a ketamine (100mg/kg)
and xyaline (10mg/kg) cocktail and 5 mm incisions were made in the skin between
the eye and the ear. The skin was carefully retraced and the exorbital lacrimal gland
was gently isolated and removed23. Skin was sutured with 6–0 black monoﬁlament
nylon (ETHILON, INC.) and the procedure was repeated on the contralateral side.
Sham-operated mice received the same procedure without gland removal.
All mice received antibiotics and analgesia for 2 days postoperatively. Corneal
abrasion was evaluated under a cobalt blue light after application of 0.5 μL of 0.25%
ﬂuorescein sodium (Bausch & Lomb Inc. Tampa, FL 33637), and was scored based
on area of corneal staining42. Tear volume was measured without anesthesia with
phenol-red cotton threads (Zone-Quick; Showa Yakuhin Kako CO., Ltd, Tokyo,
Japan)43. Brieﬂy, the threads were held with forceps and applied gently to the
lateral canthus for 30 s. Wetting of the threads was measured in millimeters under
a dissection microscope.
Tamoxifen administration. To induce CreER nuclear translocation in Trpm8creER/+
mice, animals were administered tamoxifen (T5648, Sigma) by oral gavage, according
to a protocol adapted from a previous study44. In brief, tamoxifen was freshly pre-
pared daily at 20mg/mL in olive oil (O1514, Sigma) and administered for six con-
secutive days, starting at P28. Dose administered was 40mg/kg of body weight
per day. Mice were used for experiments 4 weeks after the completion of the
tamoxifen regimen.
Single cell RT-PCR. To isolate corneal TRPM8+ neurons, TG from Trpm8EGFPf/+
mice with corneal WGA-AF555 injections were dissected and dissociated. TG
neurons were puriﬁed using a 15% BSA density gradient column. EGFPf+/AF555+
neurons cells were visually identiﬁed under a Leica DMi6000 microscope (Buffalo
Grove, IL) and manually picked using a Narishige MMO-202ND micro-
manipulator (Amityville, NY). Isolated TG neurons were ejected into PCR tubes
containing 10 µL of lysis buffer and RNase inhibitor (18080200, Life Tech), and
ﬂash frozen on dry ice and stored at −80 °C until cDNA synthesis.
cDNA was generated using Invitrogen SuperScript III CellsDirect cDNA
Synthesis Kit (18080200, Life Tech), according to the manufacturer’s
recommended protocol. RT-PCR was performed using 2 µL cDNA and Qiagen
HotStar Taq Polymerase (203203, Qiagen). RT negative control: No reverse
transcription reaction on RNA sample from whole TG (to exclude the
contamination from genomic DNA). Positive control: cDNA from the whole TG.
Gene speciﬁc primers are listed in Table 1 . Uncropped images of the veriﬁed gels
are provided in the Data Source.
Table 1 Genetic speciﬁc primers for single cell RT-PCR.
Gene Forward Primer Reverse Primer Anneal Amplicon Size (bp)
Trpv1 ACCACGGCTGCTTACTATCG CGGAAATAGTCCCCAACGGT 52 °C 77
Tac1 CGGCCAAGGAGAGCAAAGA ACGGCCACGAGGATTTTCAT 62 °C 96
Gapdh CCCAGCAAGGACACTGAGCAA TTATGGGGGTCTGGGATGGAAA 65 °C 93
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Enzyme-Linked Immunosorbent Assay (ELISA). To measure substance P (SP)
release, dissociated TG neurons were seeded onto the 7mm glass window of a 35mm
glass bottom dish (MatTek Corporation) and cultured at 37 °C for 18–24 h before
use. To stimulate the neurons, culture media was gently rinsed away, replaced with
50 µL of CIB containing vehicle or stimulants, and incubated at 37 °C for 5 min.
Cold stimulation was generated by bath temperature drop from 32 °C to
15 °C. The interval between ﬁrst and second cold stimulations was 5 h. SP containing
supernatant was collected for Enzyme-Linked Immunosorbent Assay (ELISA).
SP concentration was measured using an ELISA kit (ADI-900–018, Enzo Life
Sciences) and BioTek Synergy H4 plate reader. SP concentration was determined
using the manufacturer’s supplied standards and recommended protocol.
Intracisternal injection. To pharmacologically block the substance P receptor,
mice received intracisternal injection of NK1-angtagonist L733,060 hydrochloride.
Brieﬂy, adult C57BL/6 J wild-type male mice were anesthetized with 2% isoﬂurane
during the procedure. L733,060 hydrochloride (10 µg in 5 µL) was injected slowly
into the cisterna magna. Behavioral tests were performed 30 min after injection.
Acetone test. Mice were placed in acrylic testing chambers on an elevated wire
mesh ﬂoor. After a habituation period of 30 min, 15–20 µL of acetone was gently
applied onto the plantar surface of the hind paw. Responses were scored and
analyzed as previously described45, and were graded as follows: 0, no response; 1,
brisk withdrawal or ﬂick of the paw; 2, repeated ﬂicking of the paw; 3, repeated
ﬂicking and licking of the paw46.
Hargreaves test. Hargreaves test was used to measure the thermal sensitivity as
previously described47. In brief, mice were placed in acrylic testing chambers on a
heated (30 °C) glass plate (IITC Life Science). The radiant heat source was delivered
to the plantar surface of the hind paw and withdrawal latencies were scored.
Data analysis. Data are shown as means ± s.e.m. Statistical signiﬁcances were
determined using t-test (for two groups) or one-way ANOVA followed by a Tukey-
Kramer post hoc test (for three or more groups). Difference between groups is
considered statistically signiﬁcant if P < 0.05.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the ﬁndings of this study are available
within the paper and its supplementary information ﬁles. The raw data underlying
Figs. 1b, c, e, f, 2b, d, 3b, d, f, g, i, j, l, m, 4a–d, f, 5b–h, 6c, e–j, 7b–f and Supplementary
Figs. 1, 2, 3, 4, 5, 6g, 7, 8, 9 and 10b are provided as a Source Data ﬁle. No restrictions on
data availability.
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